References
- Anand P, Kunnumakkara AB, Newman RA, et al. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm. 4(6): 807–818.
- Anand P, Sundaram C, Jhurani S, et al. (2008). Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett. 267(1): 133–164.
- Batycky RP, Hanes J, Langer R, et al. (1997). A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci. 86(12):1464–1477.
- Dinarvand R, Mahmoodi S, Farboud E, Salehi M, Atyabi F. (2005). Preparation of gelatin microspheres containing lactic acid-effect of cross-linking on drug release. Acta Pharm. 55(1): 57–67.
- Esposito E, Cortesi R, Nastruzzi C. (1996). Gelatin microsphere: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials. 17(20): 2009–2020.
- Esposito E, Pastesini C, Cortesi R, et al. (1995). Controlled release of 1-/3-D-arabinofuranosylcytosine (ara-C) from hydrophilic gelatin microspheres: in vitro studies. Int. J. Pharm. 117: 151–158.
- Freiberg S, Zhu XX. (2004). Polymer microspheres for controlled drug release. Int. J. Pharm. 282(1-2): 1–18.
- Gallo JM, Gupta PK, Hung CT et al. (1989). Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J Pharm Sci. 78(3): 190–194.
- Ghaderi R, Struesson C, Carlfors J. (1996). Effect of preparative parameters on the characteristics of poly (d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm. 141: 205–216.
- Ikada Y, Tabata Y. (1998). Protein release from gelatin matrices. Adv Drug Deliv Rev. 31: 287–301.
- Illum L, Davis SS, Wilson CG, et al. (1982). Blood clearance and organ deposition of intravenously administered colloidal particles: The effects of particle size, nature and shape. Int. J. Pharm. 12: 135–146.
- Iwanaga K, Yabuta T, Kakemi M, et al. (2003). Usefulness of microspheres composed of gelatin with various cross-linking density. J. Microencapsul. 20(6): 767–776.
- Jain A, Gupta Y, Jain SK. (2007). Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target. 15(4): 285–294.
- Jemal A, Siegel R, Ward E, et al. (2007). Cancer statistics, 2007. CA Cancer J. Clin. 57(1): 43–66.
- Kanke M, Simmons GH, Weiss DL, et al. (1980). Clearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci. 69(7):755–762.
- Kawai K, Suzuki S, Tabata Y, et al. (2000). Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 21(5): 489–499.
- Lee J, Im YH, Jung HH, et al. (2005). Curcumin inhibits interferon-alpha induced NF- kappa B and COX-2 in human A549 non-small cell lung cancer cells. Biochem and Biophys Res Communs. 334(2): 313–318.
- Lim ST, Forbes B, Martin GP, et al. (2001). In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS Pharm Sci Tech. 2 (4): E20.
- Lu B, Zhang JQ, Yang H. (1999). Studies on lung targeting gelatin microspheres of carboplatin. Acta Pharmaceutica Sinica. 34: 786–789.
- Lu B. (1998).New Techniques and New Dosage Forms of Drugs. Beijing, China: People’s Health Publishing House.
- Lv Q, Yu A, Xi Y, et al. (2009). Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372(1-2): 191–198.
- Ma ZS, Shayeganpour A, Brocks DR, et al. (2007). High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. J. Biomed Chromatogr. 21(5): 546–552.
- Maheshwari RK, Singh AK, Gaddipati J, et al. (2006). Multiple biological activities of curcumin: A short review. Life Sci. 78(18): 2081–2087.
- Mathew ST, Devi SG, KV S. (2007). Formulation and Evaluation of Ketorolac Tromethamine-loaded Albumin Microspheres for Potential Intramuscular Administration. AAPS Pharm Sci Tech. 8 (1): E14.
- Menon LG, Kuttan R, Kuttan G. (1995). Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95(1-2): 221–225.
- Mladenovska K, Kumbaradzi E, Dodov G, et al. (2002). Biodegradation and drug release studies of BSA loaded gelatin microspheres. Int. J. Pharm. 242(1-2): 247–249.
- Mu L, Feng SS. (2001). Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control Release. 76(3): 239–254.
- Muvaffak A, Gurhan I, Hasirci N. (2004). Prolonged cytotoxic effect of colchicine released from biodegradable microspheres. J Biomed Mater Res B Appl Biomater. 71(2): 295–304.
- Nanji, AA, Jakelainen, K, Fotouhinia, M, et al. (2001). Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin and chemokines. Am J Physiol Gastrointest Liver Physiol. 281(6): 1348–1356.
- Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP. (2007). Eudragit-coated Pectin Microspheres of 5-Fluorouracil for Colon Targeting. AAPS Pharm Sci Tech. 8(1): E12.
- Pan MH, Huang TM, Lin JK. (1999). Biotransformation of Curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27(4): 486–494.
- Prior S, Gamazo C, Irache JM, et al. (2000). Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int. J. Pharm. 196(1):115–125.
- Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. (2004). Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett. 208(2): 163–170.
- Rahman Z, Kohli K, Khar RK, Ali M, Charoo NA, Shamsher AA. (2006). Characterization of 5-Fluorouracil Microspheres for Colonic Delivery. J. AAPS Pharm Sci Tech. 7(2): E47.
- Raouf G, Cecilia S, Johan C. (1996). Effect of preparative parameters on the characteristics of poly (d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm. 4: 205–216.
- Sahu A, Bora U, Kasoju N, Goswami P. (2008). Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)–palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia. 4 (6): 1752–1761.
- Sharma RA, Steward WP, Gescher A. (2007). Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology. 595: 453–470.
- Tabata Y, Nagano A, Ikada Y. (1999). Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5(2):127–138.
- Wang SN, Deng YH, Zheng SH, et al. (2003). Studies on preparation of ciprofloxacin liposomes and its tissue distribution in mice. Chin Pharm J. 38: 274–277.
- Wang YJ, Pan MH, Cheng AL, et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 15(12): 1867–1876.
- Yoshioka T, Hashlda M, Muranishi et al. (1981). Specific delivery of mitomyein C to the liver, spleen and lung: nano and mierospherical carriers of gelatin. Int. J. Parm. 8: 131–139.
- Zeng FB, Lu B, Yang H, et al. (1996). Studies on gelatin microsphere loaded ligustrazine hydrochloride for lung targeting. Yao Xue Xue Bao. 31(2): 132–137.